← Back to Search
Preparation, Characterization And In Vivo Evaluation Of A Combination Delivery System Based On Hyaluronic Acid/jeffamine Hydrogel Loaded With PHBV/PLGA Blend Nanoparticles For Prolonged Delivery Of Teriparatide
N. B. Javan, H. Montazeri, Leila Rezaie Shirmard, N. J. Omid, Ghullam Reza Barbari, M. Amini, M. Ghahremani, M. Rafiee-Tehrani, F. Dorkoosh
Published 2017 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
ABSTRACT In the current study, biodegradable PHBV/PLGA blend nanoparticles (NPs) containing Teriparatide were loaded in hyaluronic acid/jeffamine (HA‐JEF ED‐600) hydrogel to prepare a combination delivery system (CDS) for prolonged delivery of Teriparatide. The principal purpose of the present study was to formulate an effective and prolonged Teriparatide delivery system in order to reduce the frequency of injection and thus enhance patient's compliance. Morphological properties, swelling behaviour, crosslinking efficiency and rheological characterization of HA‐JEF ED‐600 hydrogel were evaluated. The CDS was acquired by adding PHBV/PLGA NPs to HA‐JEF ED‐600 hydrogel simultaneously with crosslinking reaction. The percentage of NPs incorporation within the hydrogel as well as the loading capacity and morphology of Teriparatide loaded CDS were examined. Intrinsic fluorescence and circular dichroism spectroscopy proved that Teriparatide remains stable after processing. The release profile represented 63% Teriparatide release from CDS within 50 days with lower burst release compared to NPs and hydrogel. MTT assay was conducted by using NIH3T3 cell line and no sign of reduction in cell viability was observed. Based on Miller and Tainter method, LD50 of Teriparatide loaded CDS was 131.8 mg/kg. In vivo studies demonstrated that Teriparatide loaded CDS could effectively increase serum calcium level after subcutaneous injection in mice. Favourable results in the current study introduced CDS as a promising candidate for controlled delivery of Teriparatide and pave the way for future investigations in the field of designing prolonged delivery systems for other peptides and proteins. Graphical abstract Figure. No Caption available.
This paper references
A novel composite drug delivery system: honokiol nanoparticles in thermosensitive hydrogel based on chitosan.
X. Li (2009)
A Simple Parallel Plate Flow Chamber to Study Effects of Shear Stress on Endothelial Cells
H. Kaur (2012)
Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin.
K. Motokawa (2006)
Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol
Shaligram S. Rane (2012)
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis
J. Iwamoto (2006)
Protein nanoparticles for intracellular delivery of therapeutic enzymes.
L. H. Estrada (2014)
Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis.
E. Eriksen (2014)
Modification of the o-cresolphthalein complexone method for determining calcium.
S. Cohen (1979)
DETERMINATION OF MEDIAN LETHAL DOSE OF TRIAZOPHOS (TZ) WITH DMSO IN WISTAR RAT
M. Chandra (2014)
Biodegradable microspheres for protein delivery.
V. Sinha (2003)
Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
Quan Gan (2007)
Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanosphere. Part 2: Simultaneous release of a drug and a prodrug (clindamycin and clindamycin phosphate).
M. Vukomanović (2011)
In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines
K. Tománková (2015)
Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.
Jason C. Stanwick (2012)
Commercial challenges of protein drug delivery
L. Brown (2005)
The effect of nanoparticles on gastrointestinal release from modified κ-carrageenan nanocomposite hydrogels.
H. Hezaveh (2012)
Development and evaluation of sustained-release clonidine-loaded PLGA microparticles.
A. Gaignaux (2012)
An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
F. Lee (2009)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
R. Neer (2001)
Hyaluronan derivatives: Alkyl chain length boosts viscoelastic behavior to depolymerization.
M. Pavan (2013)
PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation.
U. Bhardwaj (2010)
Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide
N. B. Javan (2016)
Core/shell nanoparticles in biomedical applications.
Krishnendu Chatterjee (2014)
A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles.
Qiang Peng (2012)
κ-Carrageenan hydrogel nanocomposites with release behavior mediated by morphological distinct Au nanofillers.
A. M. Salgueiro (2013)
In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold.
X. H. Zhu (2009)
Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system.
Chunhui Hu (2012)
Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
E. J. Oh (2010)
Network connectivity, mechanical properties and cell adhesion for hyaluronic acid/PEG hydrogels.
S. Ouasti (2011)
In-vitro Release Study of Carvedilol Phosphate Matrix Tablets Prepared with Hydroxypropyl Methylcellulose
Shimul Halder (2012)
A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
L. Mayol (2008)
PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
N. Csaba (2006)
Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis.
D. Narayanan (2012)
Poly(lactide-co-glycolide) Nanoparticles for an Extended Delivery of Bevacizumab to Retina: Formulation and In Vitro Characterization
J. Pandit (2014)
Hyaluronan concentration within a 3D collagen matrix modulates matrix viscoelasticity, but not fibroblast response.
S. Kreger (2009)
Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin.
Q. Peng (2013)
Cytotoxicity of Agaricus sylvaticus in non-tumor cells (NIH/3T3) and tumor (OSCC-3) using tetrazolium (MTT) assay.
J. V. C. Orsine (2013)
Modeling of drug release from bulk-degrading polymers.
L. L. Lao (2011)
Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells.
C. Vilos (2013)
Hydrogel nanoparticles for drug delivery.
M. Dalby (2013)
Control of encapsulation efficiency and initial burst in polymeric microparticle systems
Yoon Yeo (2004)
Analysis of initial burst in PLGA microparticles
S. Allison (2008)
Precise tailoring of tyramine-based hyaluronan hydrogel properties using DMTMM conjugation.
C. Loebel (2015)
The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres.
G. Wei (2004)
Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres
J. Zhang (2005)
Mechanical properties and degradation behaviors of hyaluronic acid hydrogels cross-linked at various cross-linking densities
O. Jeon (2007)
Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells.
J. Kim (2007)
Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation.
Y. Geng (2008)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund (2013)
Drugs Used to Treat Osteoporosis: The Critical Need for a Uniform Nomenclature Based on Their Action on Bone Remodeling
B. Riggs (2005)
Combination of Hyaluronic Acid Hydrogel Scaffold and PLGA Microspheres for Supporting Survival of Neural Stem Cells
Y. Wang (2011)
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
J. A. Wieland (2007)
Analysis of initial burst in PLGA microparticles.
S. Allison (2008)
Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.
Elena Tous (2012)
Protein secondary structure and circular dichroism: a practical guide. Proteins: Structure, Function, and Bioinformatics
W. Johnson (1990)
Mechanisms of tryptophan fluorescence shifts in proteins.
J. Vivian (2001)
Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds.
J. Leach (2005)
Preparation, characterization and optimization of glipizide controlled release nanoparticles
J. Emami (2014)
Estimation of the ED50 and Its Error by Means of Logarithmic-Probit Graph Paper.∗
L. Miller (1944)
Teriparatide: A bone formation treatment for osteoporosis.
E. Eriksen (2004)
Sustained release of PTH(1-34) from PLGA microspheres suppresses osteoarthritis progression in rats.
Rajalakshmanan Eswaramoorthy (2012)
High throughput screening of protein formulation stability: practical considerations.
M. Capelle (2007)
Microspheres prepared with biodegradable PHBV and PLA polymers as prolonged-release system for ibuprofen: in vitro drug release and in vivo evaluation
G. Bazzo (2012)
Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer.
J. Lee (2011)
Assessing nanotoxicity in cells in vitro.
Jedd M. Hillegass (2010)
bination of hyaluronic acid hydrogel scaffold and PLGA microspheres for supporting survival of neural stem cells
Y. Wang (2011)
What is the optimal duration of bisphosphonate therapy?
S. Ott (2011)
Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern.
Tatiana Segura (2005)
Protein secondary structure and circular dichroism: A practical guide
W. C. Johnson (1990)
Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition.
S. Hahn (2006)
Recent advances in protein and peptide drug delivery systems.
Dhirendra Kumar Malik (2007)
The clinical epidemiology of male osteoporosis: a review of the recent literature
T. Willson (2015)
Smart polymers for controlled delivery of proteins and peptides: a review of patents.
L. R. Fogueri (2009)
Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery.
M. Vukomanović (2011)
Ionically cross-linked hyaluronic acid: wetting, lubrication, and viscoelasticity of a modified adhesion barrier gel
K. Vorvolakos (2011)
Modus operandi of controlled release from mesoporous matrices: a theoretical perspective.
T. Ukmar (2011)
Hydrogels as extracellular matrix mimics for 3D cell culture.
Mark W. Tibbitt (2009)
Ceftiofur-loaded PHBV microparticles: A potential formulation for a long-acting antibiotic to treat animal infections
C. Vilos (2012)
Understanding controlled drug release from mesoporous silicates: theory and experiment.
T. Ukmar (2011)
Effect of methionine oxidation and deletion of amino-terminal residues on the conformation of parathyroid hormone. Circular dichroism studies.
J. Zull (1990)
A novel PHBV/HA microsphere releasing system loaded with alendronate
W. Huang (2009)
The Effects of Excipients and Particle Engineering on the Biophysical Stability and Aerosol Performance of Parathyroid Hormone (1-34) Prepared as a Dry Powder for Inhalation
S. Shoyele (2011)
PHBV/PCL Microparticles for Controlled Release of Resveratrol: Physicochemical Characterization, Antioxidant Potential, and Effect on Hemolysis of Human Erythrocytes
Jessica Bitencourt Emilio Mendes (2012)
A new highly viscoelastic hyaluronic acid gel: rheological properties, biocompatibility and clinical investigation in esthetic and restorative surgery.
T. Iannitti (2013)
Calculation of LD50 values from the method of Miller and Tainter, 1944.
M. A. Randhawa (2009)
Hydrogel nanoparticles in drug delivery.
M. Hamidi (2008)
Stability and physicochemical characteristics of PLGA, PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: A comparative study
M. J. Santander-Ortega (2007)
Parathyroid hormone: synthesis, secretion, and action
E. Brown (2006)
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Yolanda Parajó (2010)
Synthesis and degradation test of hyaluronic acid hydrogels.
S. Hahn (2007)
The importance of toxicity testing
D. Arome (2013)
Optimization and characterization of diclofenac sodium microspheres prepared by a modified coacervation method.
E. S. El-Leithy (2010)
Significance of the LD50-test for the toxicological evaluation of chemical substances
G. Zbinden (2004)
This paper is referenced by
Chitosan hydrogel covalently crosslinked by gold nanoparticle: Eliminating the use of toxic crosslinkers
Fernanda Silva Tenório (2020)
High Performance Liquid Chromatography-Size Exclusion Chromatography (Hplc-Sec) As an Efficient Tool for The Quantification of Polymers
Deepak D. Kayande (2019)
Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system
Behnoush Alizadeh (2018)
Influence of CNT pre-dispersion into PHBV/CNT nanocomposites and evaluation of morphological, mechanical and crystallographic features
Thaís L. A. Montanheiro (2019)
Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate
Leila Rezaie Shirmard (2020)
Improved anti‐colorectal carcinomatosis effect of tannic acid co‐loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel
Yutao Ren (2019)
Hydrogels Based Drug Delivery Synthesis, Characterization and Administration
Anca Onaciu (2019)
A brief review concerning the latest advances in the influence of nanoparticle reinforcement into polymeric-matrix biomaterials
T. L. A. Montanheiro (2020)
Preparation and characterization of dry powder containing sunitinib loaded PHBV nanoparticles for enhanced pulmonary delivery
Maryam Otroj (2020)
Design of polymer-based antimicrobial hydrogels through physico-chemical transition.
E. Mauri (2019)
Study the role of poly(diethyl aminoethyl methacrylate) as a modified and grafted shell for TiO2 and ZnO nanoparticles, application in flutamide delivery
A. A. Ensafi (2017)
Development of a fast and precise method for simultaneous quantification of the PLGA monomers lactic and glycolic acid by HPLC
Marcel Pourasghar (2019)